HPV

  1. This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.
    Published: September 2018
    Type: Resource Page
  2. There is broad recognition of the growing and inequitable burden of cervical cancer in low-resource countries, and uptake of new screening and treatment alternatives for adult women and human papillomavirus (HPV) vaccines for young adolescent girls is on the rise. For the first time in history the elimination of the disease is within reach, and on May 19, 2018, WHO Director-General, Dr. Tedros Adhanom Ghebreyesus made a global call for action on cervical cancer elimination. This fact sheet summarizes PATH's current work and future priorities.
    Published: July 2018
    Type: Resource Page
  3. Aisha was wearing her blue school uniform and wiping tears from her face. She’d just been vaccinated, but it wasn’t the shot that upset her. She was crying because her mother died of the very disease she was being protected from—cervical cancer.
    Published: June 2018
    Type: Article
  4. Leading health and research institutions come together to evaluate the evidence for potential single-dose HPV vaccination schedule
    Published: January 2018
    Type: Announcement
  5. PATH’s Scale-Up project works to expand the use of human papillomavirus (HPV) testing for cervical cancer prevention. Based on PATH’s experience implementing the careHPV™ test in Central America, these tools provide guidance for organizing a quality assurance program to screening programs adopting the careHPV test.
    Published: November 2017
    Type: Resource Page
  6. This brochure outlines PATH's work in China, where we collaborate with government agencies, nongovernmental organizations, research institutes, and manufacturers to improve health and save lives. With technical assistance from PATH, China is becoming a leading supplier of lifesaving health technologies and products for use in low-resource settings. Programmatic areas include tuberculosis, vaccines and immunization, neglected tropical diseases, and reproductive health.
    Published: February 2017
    Type: Resource Page
  7. This brochure outlines PATH’s work to improve health in Uganda. Key areas of focus include cervical cancer prevention, detection, and treatment; vaccines and immunization, including supply chain improvements; advocacy to improve the quality and availability of health care services; and introduction of Sayana® Press, a popular new form of injectable contraceptive.
    Published: January 2017
    Type: Resource Page
  8. PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers a wide variety of high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. It is geared for health professionals in the developing and industrialized worlds, as well as for journalists, policymakers, community leaders, parents, and others interested in vaccine-related resources. The resources found on the VRL are collected from a variety of sources, including news media, scientific journals, and leaders in public health.
    Published: January 2017
    Type: Resource Page
  9. RHO Cervical Cancer is an online resource for health program managers and decision-makers seeking to prevent cervical cancer in low-resource settings. The site contains information about human papillomavirus and cervical cancer, cervical cancer screening and treatment, and the role of vaccination in cervical cancer prevention.
    Published: January 2017
    Type: Resource Page
  10. PATH conducted a landscape analysis of cervical cancer screening in Kenya, Tanzania, and Uganda to clarify opportunities for HPV testing as a primary cervical cancer screening method in these countries. We conducted stakeholder interviews and meetings in each country to discuss the decision-making process for test introduction, potential advantages of HPV testing, and anticipated barriers to introduction and ways to overcome them.
    Published: December 2016
    Type: Resource Page
Load more